Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- 2 Influenza Drugs Faced Shortage This Season
April 14, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
April 14, 2003
- Kissei Licenses Mitiglinide to Choongwae of South Korea
April 14, 2003
- Matsumotokiyoshi's Profit Forecasts Revised Upward by Security Analysts
April 14, 2003
- Chugai to Focus on Proper Use Following Launch of Xeloda
April 14, 2003
- Sugi Pharmacy: Sales, Profits Increase Remarkably
April 14, 2003
- Toho Reorganizes with Kyoso Mirai Group
April 14, 2003
- OTC NEWS IN BRIEF
April 14, 2003
- EPS to Start CRA Dispatch Business
April 14, 2003
- Doctors Strongly Interested in Advanced Medical Devices: Survey
April 14, 2003
- BUSINESS NEWS IN BRIEF
April 14, 2003
- MEDICAL DIVICE NEWS IN BRIEF
April 14, 2003
- CDFS Recommends Designation of Bio-derived Products
April 7, 2003
- Janssen's Sales Top \50 Bil., 4th Double-Digit Growth in 4 Years: President Sekiguchi
April 7, 2003
- Patient Meal Market to Grow 25% by 2007: Report
April 7, 2003
- PRESS SEMINAR
April 7, 2003
- Otsuka Licenses Dry Powder Inhaler from Innovata Biomed
April 7, 2003
- 10% Elderly Copayment Puts Brake on Patient Visits: CareNet Survey
April 7, 2003
- Number of Drugstores Up 34% to 14,673 in 2002: METI Statistics
April 7, 2003
- Generics Will Cut Mevalotin Sales "No More than 10%" Sankyo
April 7, 2003
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…